Aurinia Pharmaceuticals
AUPH
AUPH
64 hedge funds and large institutions have $113M invested in Aurinia Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
79% less call options, than puts
Call options by funds: $595K | Put options by funds: $2.79M
Holders
64
Holding in Top 10
–
Calls
$595K
Puts
$2.79M
Top Buyers
| 1 | +$1.69M | |
| 2 | +$1.24M | |
| 3 | +$1.21M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$1.04M |
| 5 |
Goldman Sachs
New York
|
+$246K |
Top Sellers
| 1 | -$6.08M | |
| 2 | -$2.43M | |
| 3 | -$2.27M | |
| 4 |
AIC
AWM Investment Company
New York
|
-$1.61M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.1M |